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Abstract
Dendritic cells (DC) represent a heterogeneous class of antigen presenting cells (APC). Previously we reported a distinct myeloid den-
dritic-like cell present in spleen, as an in vivo counterpart to cells produced in murine spleen long-term cultures (LTC-DC). These cells,
named ‘L-DC’, were found to be functionally and phenotypically distinct from conventional (c)DC, plasmacytoid (p)DC and monocytes.
These results suggested that spleen may represent a niche for development of L-DC from endogenous progenitors. Adult murine spleen
has now been investigated for the presence of L-DC progenitors. Lineage-negative (Lin)ckitlo and Linckithi progenitor subsets were
identified as candidate populations, and tested for ability to produce L-DC; in vitro upon co-culture with the spleen stromal line STX3,
and in vivo after adoptive therapy into mice. Both subsets colonized STX3 stroma in vitro for L-DC production, indicating that they con-
tained either a common or two distinct progenitors for L-DC. However, only the Linckithi subset gave progeny cells after adoptive trans-
fer into lethally irradiated mice. In vivo development was however multilineage and not restricted to L-DC development. Multilineage
reconstitution reflects long-term reconstituting haematopoietic stem cells (LT-HSC), suggesting a close relationship between L-DC pro-
genitors and LT-HSC. L-DC were however produced in vivo in much higher number than monocytes/macrophages and cDC, indicating
the presence of a specific L-DC progenitor within the Linckithi subset. A model is advanced for development of L-DC directly from
haematopoietic progenitors in spleen and dependent on the spleen microenvironment.
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Introduction
The mouse is a well-recognized model for studying haematopoiesis.
At birth, HSC migrate from foetal liver to bone where they remain
for the life of the animal. HSC also appear in mouse spleen soon
after birth [1] and are maintained there for life. They also exist in
extramedullary sites and small numbers mobilize through blood
and lymph into tissues like spleen, liver, lung, brain and intestine
in the steady-state [2, 3]. The number of haematopoietic stem/
progenitor cells (HSPC) in blood, spleen and liver also expands
noticeably following acute inflammation or drug treatment [4, 5].
The small number of progenitors in extramedullary tissues in the
steady-state should not discount their importance or potential
contribution to the immune response. Findings from this labora-
tory indicate that spleen in the steady-state does contain HSC
detectable by their long-term reconstitution ability upon adoptive
transfer to irradiated host mice [6]. The importance of bone mar-
row (BM) in haematopoiesis is clear however since neonatally
splenectomized mice can maintain normal BM haematopoiesis 
[1, 6]. The relative haematopoietic contribution of HSC from
spleen and BM of adults is however not known, and it has long
been assumed that spleen fills the role of an emergency or backup
site in times of stress or disease.
Spleen is also a central organ for development of DC that take
up and present antigen to lymphocytes. Multiple subsets have
been identified including the CD8 and CD8 conventional
(c)DC and plasmacytoid (p)DC [7], and the less well-defined reg-
ulatory DC [8–10]. Monocyte-derived DC (moDC) are also found
in spleen but only under conditions of inflammation [11]. An
essential element of DC biology is the definition of progenitors
and precursors since this underpins the formation of lineages of
cells with distinct function. Initially, cDC and pDC progenitors
were defined as a Flt3 subset amongst common myeloid and
lymphoid progenitors (CMP/CLP) [12]. Current evidence points
to a common monocyte/dendritic progenitor (MDP) in BM which
gives rise to all monocyte/macrophage and dendritic-type cells
[13, 14], and a more committed common dendritic progenitor
(CDP) for cDC and pDC in BM [15, 16]. While CDP and MDP are
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not present in spleen or blood [17], spleen does harbour cDC 
precursors, which have a high turnover and are replaced by
blood-borne precursors [18]. There is also evidence from parabi-
otic mouse studies to suggest that some splenic DC might arise
from endogenous progenitors [19], although others have ques-
tioned that result [20].
In this laboratory, a novel dendritic-like antigen presenting cell
was discovered in spleen on the basis of similarity with dendritic-
like cells developing in splenic long-term cultures (LTC) [21, 22].
‘LTC-DC’ have a characteristic immature phenotype as
CD11cloCD11bhiMHC-IICD8 cells, distinguishing them from
cDC, pDC and monocytes [22, 23]. They are also distinguishable
as large, endocytic cells specialized in cross-presentation of anti-
gen to CD8 T cells [24], a function usually attributed to CD8
cDC [25]. They are also distinct in their very weak ability to acti-
vate CD4 T cells, consistent with their MHC-II phenotype. Since
they can be derived from GM-CSF/ mice [26], they are distinct
from moDC [11] or ‘Tip-DC’ [27] that develop in response to
inflammatory factors like GM-CSF/TNF-. The in vivo equivalent
‘L-DC’ subset is readily distinguishable from cDC, pDC and mono-
cytes on the basis of CD11b and CD11c expression, as well as
many other markers including CD8, MHC-II, CD205 and myeloid
markers like Ly6G and Mac3 [24]. L-DC show similar antigen
cross presenting function as LTC-DC [24] and are functionally dis-
tinct from described subsets of regulatory DC which inhibit T cell
proliferation [8–10]. The ontogeny and lineage origin of this sub-
set appears to be distinct from other known DC and myeloid sub-
sets in spleen.
It is hypothesized that spleen maintains a lineage of dendritic-
like cells, which arise from endogenous haematopoietic progeni-
tors maintained in spleen. Such tissue-specific production of DC
has been previously reported for Langerhans cells in skin which
are continuously renewed from radio-resistant, skin-derived pro-
genitors [28], only being replaced by blood-borne progenitors
under inflammatory conditions [29]. Splenic stromal cells which
support haematopoiesis of L-DC in vitro have been shown to have
an endothelial origin [30, 31], and L-DC have been shown to arise
in co-cultures of BM progenitors or spleen subsets over a splenic
stromal cell line [32]. Both neonatal and adult splenocytes contain
progenitors that produce L-DC when co-cultured over STX3 spleen
stroma [33]. This study identifies and characterizes L-DC progen-
itors in adult spleen in terms of capacity to produce L-DC in 
stromal co-cultures and to undergo haematopoiesis for L-DC pro-
duction upon transplantation into irradiation chimeras.
Materials and methods
Animals
C57BL/6J and C57BL/6.SJL-PtprcaPep3b/BoyJ (B6.SJL) mice were bred at
the John Curtin School of Medical Research (Canberra, Australia) under
specific pathogen-free conditions and used at 4–6 weeks of age.
Antibody staining
Antibody staining and flow cytometry were performed to analyse cell sur-
face marker expression as described previously [33]. Non-specific anti-
body binding via Fc receptors was blocked by incubating cells (106) with
anti-CD16/32 (FcR block) (eBioscience, San Diego, CA, USA). Biotin- or
fluorochrome-conjugated antibodies specific for CD11c (N418), CD11b
(M1/70), ckit (2B8), IL-7R (A7R34), CD45.1 (A20), CD19 (1D3), B220
(RA3–6B2), Thy1.2 (30-H12) and CD34 (RAM34) were purchased from
eBioscience. Antibodies specific for CD8 (53–6.7), Sca1 (E13–161.7) and
MHC-II (25–9-17) were purchased from Becton Dickinson (San Jose, CA,
USA). Isotype control antibodies were purchased from eBioscience.
Propidium iodide (PI: 1 g/ml; Sigma-Aldrich, St. Louis, MO, USA) was
added prior to flow cytometry for discrimination of live and dead cells. Flow
cytometry was performed immediately on a BD LSRII flow cytometer
(Becton Dickinson). Data collected included forward scatter (FSC), side
scatter (SSC) and multiple fluorescence channels detecting FITC, CFSE,
PE, PI, PE-Cy7, APC and APC-Cy7 (channels FL1-4, FL9-10). BD FACSDiva
Software (Becton Dickinson) was used to acquire data. Data analysis
involved post-acquisition gating using FlowJo software (Tree Star,
Ashland, OR, USA). Cells sorting was performed using a FACSAria cell
sorter (Becton Dickinson) as described previously [33].
Enrichment for spleen precursors
Whole splenocytes were enriched for precursors by negative depletion of
T cell and B cell populations using antibody-coated magnetic beads as
described previously [33], which are specific for CD19 (eBio1D3), Thy1.2
(30-H12) and TER-119, (eBioscience). Recovered cells were washed and
then stained with antibody for subsequent isolation of subsets by sorting.
Co-culture assays to assess DC development
Spleen stromal line STX3 is a spleen stromal cell line derived from a long-term
culture which ceased production of DC over time with passage [34]. STX3
grows as a confluent monolayer and is passaged by scraping and cell transfer-
ral. When spleen or BM cells are co-cultured over STX3 (1–5  105 cells/ml),
haematopoiesis is established and myeloid dendritic-like cells are produced.
For co-culture maintenance, half medium is exchanged every 3–4 days and
non-adherent cells are collected for flow cytometric analysis.
Production of murine chimeras
Chimeras were generated using CD45-allotype distinct donor and host
mice as described previously [24]. Haematopoietic cells (CD45.1) were
transferred intravenously into lethally irradiated hosts (9.5 Gy) to assess 
in vivo reconstitution potential of blood cell lineages. Recipients were also
given host (CD45.2) BM (105 cells) to ensure survival.
Statistical analysis
Data are presented as mean  S.E., n 	 3. With only small sample sizes,
a normal distribution cannot be assumed. The Wilcoxon Rank Sum Test
was therefore used to assess significance (P  0.05).
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Results
Characterization of L-DC progenitors in adult spleen
Candidate progenitor subsets were identified in adult spleen fol-
lowing staining with markers for HSPC (Fig. 1). A significant frac-
tion of cells (10%) was found to be ckitloCD11chi cells, a popula-
tion reflective of cDC [35]. CD11c cells expressing ckit were thus
excluded from further analysis. The remaining Linckit cells
could be divided into subsets of Linckitlo and Linckithi cells,
representing ~3% and 1.7% of cells, respectively (Fig. 1A). These
were analysed for expression of other known haematopoietic
markers [36]. Sca1 was expressed on only ~3% of Linckithi cells,
and the HSPC markers CD34 and Flt3 (not shown) were not
expressed on Linckit cells. The absence of HSPC in spleen
expressing CD34 or Flt3 has been confirmed by others [17, 20].
IL-7R, a marker of lymphoid progenitors in BM [37], was also
absent, while a large population of cells were found to be
LinckitCD11b (61%), reflecting myeloid precursors.
Differentiation of splenic progenitors in co-cultures
In line with marker analysis shown in Figure 1A, splenocytes
depleted of T and B cells (Thy1.2CD19) were gated by flow
cytometry to exclude CD11cCD11b cells and sorted to give
Linckit, Linckitlo and Linckithi subsets (Fig. 1B). Each of
these populations was then co-cultured over STX3 stroma to
assess differentiative potential. Linckit adult spleen precursors
failed to produce progeny cells (Fig. 2A and B). In contrast, sorted
Linckithi progenitors generated a high yield of large (FSChi) cells,
reflecting two distinct populations of myeloid DC, including
CD11bhiCD11cloMHC-II L-DC (round gates) and CD11bloCD11chi
MHC-II cDC-like cells (square gates). At 15 days after establish-
ment of co-cultures with Linckithi cells (Fig. 2A), MHC-II
Fig.  1 Identification and isolation of
haematopoietic progenitors in adult spleen.
Spleen cell suspensions were prepared by
depletion of red blood cells, and T and B cell
depletion using magnetic beads. Cells were
stained with fluorochrome-conjugated anti-
bodies against ckit, Sca1, CD34, IL-7R,
CD11c and CD11b. Prior to flow cytometry,
propidium iodide (PI; 1 g/ml) was added to
allow gating of live (PI) cells. (A) Cells were
gated based on forward scatter (FSC) and
side scatter (SSC) parameters to exclude
debris. Initial phenotype analysis involved
ckit versus CD11c expression. Further
marker analysis excluded CD11c spleen
cells. Percent positive cells are indicated in
quadrants and square gates. (B) For sorting
progenitors, adult T and B cell depleted
splenocytes were stained with fluorochrome-
conjugated antibodies against ckit, CD11c
and CD11b. Live (PI) cells were gated to
give Lin (Thy1.2CD19CD11cCD11b)
ckit, ckitlo and ckithi cell populations.
Results are representative of multiple inde-
pendent experiments.
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cDC-like cells represented a minor population of cells (8.4%),
while L-DC accounted for 59% of cells produced. Thereafter, the
production of MHC-II cDC declined 16-fold over 30 days of co-
culture (Fig. 2B). The development of MHC-II DC was thus tran-
sient, consistent with development from a preformed precursor,
perhaps a ckitCD11clo contaminant. In contrast, co-cultures
established with Linckitlo precursors produced exclusively L-DC
and no MHC-II cDC-like cells. Although Linckitlo splenocytes
were restricted in their production of only L-DC, higher yields of L-
DC were achieved in Linckithi co-cultures (Fig. 2B). Production of
L-DC in co-cultures established with Linckitlo and Linckithi pro-
genitors was minimal by 15 days and peaked at 24 days. Both
Linckitlo and Linckithi spleen fractions contained self-renewing
L-DC progenitors, with a few precursors amongst the Linckithi
subset able to develop MHC-II cDC-like cells transiently.
Absence of immediate L-DC precursors amongst
spleen Linckit progenitors
The presence of immediate L-DC precursors amongst the adult
spleen Linckit subsets was further investigated by adoptive
transfer of 5  104 sorted Linckithi or Linckitlo cells into unir-
radiated hosts, with analysis of donor progeny after 7 and 14 days
(Fig. 3). At these times, no donor-type CD11c dendritic or CD11b
myeloid progeny cells were detected in spleens of recipient mice,
Fig. 2 In vitro development of L-DC from Linckit spleen cells. Adult splenocytes were prepared as a Lin (Thy1.2CD19CD11cCD11b) subset and
sorted into specific ckit, ckitlo and ckithi subpopulations as in Figure 1. Sorted cells were cultured over STX3 stroma to assess developmental potential
for L-DC. (A) Progeny cells collected from co-cultures at 15, 24 and 30 days were stained with fluorochrome-conjugated antibodies specific for CD11c,
CD11b, MHC-II or isotype control antibodies. Propidium iodide (PI; 1 g/ml) staining prior to flow cytometry allowed gating of live (PI) cells for analy-
sis. Forward and side scatter parameters (FSC, SSC) were used to distinguish large-sized cells for estimation of cell yield, and multi-channel analysis.
CD11c, CD11b and MHC-II positive staining gates were defined using relevant isotype controls (shown as a density plot overlay), with percent positive
cells indicated within gates (shown as a dot plot). (B) DC production from 15, 24 and 30 day spleen Linckit, Linckitlo and Linckithi co-cultures was
scored in terms of CD11bhiCD11cloMHC-II (L-DC) and CD11bloCD11chiMHC-II (cDC-like) cell populations, and represented as percent CD11c cells,
and total yield of CD11c cells. Results are representative of multiple similar experiments.
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consistent with absence of immediate DC precursors amongst the
Linckithi and Linckitlo cell populations. Only control mice given
106 (and not 5  104) unfractionated spleen cells showed donor-
type cells in spleen (~0.001%). These were found to be mainly
CD11cCD11b. The transfer of 5  104 Linckithi or Linckitlo
cells represented a 1000-fold enrichment of progenitors over 5 
104 unfractionated spleen cells, reinforcing the conclusion that
these subsets contained no immediate precursors of L-DC.
The spleen Linckithi subset contains LT-HSC 
and L-DC progenitors
A unique characteristic of spleen LTC compared with other in vitro
DC culture systems is that productivity is sustained for years. One
explanation is that self-renewing stem cells maintained in culture
differentiate to give L-DC perhaps via formation of an L-DC progen-
itor [32, 38, 39]. The nature of progenitors amongst the Linckitlo
and Linckithi subsets was therefore tested by assessing progeny
produced following long-term reconstitution of mice with these cell
subsets. Adult splenocytes from B6.SJL (CD45.1) mice were
sorted to give Linckit, Linckitlo and Linckithi populations
which were transferred intravenously into lethally irradiated mice
along with unfractionated host-type C57BL/6J (CD45.2) BM cells
to ensure survival. Individual chimeras were assessed for lineage
reconstitution of lymphoid, myeloid and DC subsets (including 
L-DC) at 15, 16 and 18.5 weeks. Control C57BL/6J mice were 
irradiated and given BM cells from CD45.1 B6.SJL mice.
Only the spleen Linckithi subset produced progeny cells with
multilineage long-term reconstitution in 7/7 mice consistent with
the presence of LT-HSC (Fig. 4). Multilineage reconstitution by
HSC within the spleen Linckithi subset was indicated by the
detection of donor-derived DC, myeloid cells, T cells and B cells
(Fig. S1). No progeny cell reconstitution was achieved with the
spleen Linckitlo subset (0/3 mice), or with the Linckit subset
(0/4 mice), indicating absence of self-renewing progenitors or 
LT-HSC within this subset. Furthermore, in mice receiving spleen
Linckithi cells, donor-derived cells also reconstituted the corre-
sponding Linckithi stem cell compartment of spleen. Long-term,
multilineage reconstitution of hosts by LT-HSC in the spleen
Linckithi subset in comparison with BM-derived HSC was also
confirmed by analysis of chimeric mice at 54 weeks post-trans-
plantation (Table 1). Three out of four chimeras given donor
Linckithi spleen cells showed complete reconstitution 
with donor myeloid cells, while a fourth chimera showed partial
reconstitution. Control chimeras given donor-derived BM alone
also gave complete long-term multilineage reconstitution with
donor cells in three out of four mice, and also showed new HSC
production.
Capacity of spleen Linckit progenitors 
to produce DC in vivo
The distribution of APC subsets was compared in control mice and
in haematopoietic chimeras reconstituted with donor Linckithi
spleen cells or donor BM cells. Progeny subsets analysed included
CD8 cDC (CD11chiCD11bCD8MHC-II), CD8 cDC
(CD11chiCD11bCD8MHC-II), L-DC (FSChiCD11cloCD11bhiMHC-II)
and myeloid cells (FSCloCD11cCD11bhiMHC-II) (Fig. 5A). 
Fig. 3 In vivo developmental potential of isolated adult spleen Linckit precursors. Linckitlo and Linckithi spleen subsets were sorted as outlined in
Figure 1 from adult B6.SJL mice (CD45.1). Cells (5  104) were transferred intravenously into unirradiated C57BL/6J (CD45.2) recipient mice. HBSS
was injected as a ‘nil’ control, and 5  104 or 1  106 whole splenocytes were injected as positive controls. For analysis of cell development from pre-
formed precursors, spleens were collected at 7 and 14 days. The presence of donor-type DC was investigated by prior T/B cell depletion of splenocytes
and staining with CD45.1, CD11c and CD11b. Prior to flow cytometry, cells were incubated with propidium iodide (PI; 1 g/ml) for gating of live (PI)
cells. Numbers in gates indicate percent positive cells. Two further experiments (not shown) involving irradiated mice (4.5 Gy) also gave negative results.
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Fig. 4 Long-term reconstitution potential of
adult spleen Linckit cells for myeloid cell
subsets. Linckit, Linckitlo and Linckithi
spleen (SPL) subsets were sorted as
described in Figure 1 from spleens of adult
B6.SJL mice (CD45.1). Sorted cells (2.5 
104) were assessed for competitive reconsti-
tution with 105 host-type whole bone mar-
row cells by transfer into lethally irradiated
(9.5 Gy) C57BL/6J (CD45.2) recipient mice.
Dissociated whole bone marrow (CD45.1)
was transferred intravenously alone as a
positive control, and age-matched unirradi-
ated C57BL/6J mice were analysed as nega-
tive controls. To assess long-term reconsti-
tution, spleens were collected for subset
analysis at 15, 16 and 18.5 weeks, enriched
for DC by depletion of T and B cells, and
stained with fluorochrome-conjugated anti-
bodies to define donor and host cells and
their lineage. Prior to flow cytometry, cells
were incubated with propidium iodide (PI; 1
g/ml) for gating live (PI) cells. An exam-
ple analysis is shown for 16-week chimeras
stained to detect CD45.1CD11c progeny
cells (top row) and Linckit spleen progen-
itors (bottom row). The frequency of donor
cell reconstitution in chimeras after 15, 16
and 18.5 weeks is indicated.
Table 1 Representation of donor-derived haematopoietic cells in 54-week chimeras
Percent CD45.1 donor-derived cells amongst each subset
Animals* (#) CD8cDC CD8 cDC L-DC Myeloid cells B cells† T cells HSC‡
C57BL/6J control (1) 0 0 0.2 0 0 0 0
Linckithi SPL chimera (1) 0 0.2 0.2 0.1 0 0 0
Linckithi SPL chimeras (1) 78 84 100 90 17 28 97
(2) 99 97 100 92 98 92 56
(3) 37 28 61 28 85 82 49
(4) 96 97 100 96 73 82 92
BM chimeras (1) 8.2 10 23 5.7 10 77 13
(2) 99 99 100 99 74 92 97
(3) 94 94 100 98 95 87 100
(4) 100 100 100 100 90 83 81
*Chimeras were prepared as described in Figures 3 and 4. Analysis of all chimeras was performed at 54 weeks post-reconstitution. †B cells and
CD8 T cells were detected in lymph node. ‡HSC were identified in spleen as a Lin-ckithiSca1 subset.
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The latter population was also identified in terms of granulocyte
and macrophage subsets using specific antibody (data not
shown). The population distribution of DC/myeloid subsets in
spleens of chimeras was similar to control mice, indicating full
haematopoietic reconstitution (Fig. 5B). Each DC or myeloid com-
partment in spleen was restored to homeostatic levels, with
myeloid cells representing the largest population, followed by
CD8 cDC, CD8 cDC and L-DC (Fig. 5B). However, only L-DC
in spleen showed full reconstitution with donor-derived (CD45.1)
HSC present in spleen Linckithi cells or in BM (Fig. 5C). The
CD8 cDC, CD8 cDC and myeloid cell compartments were
only partially replaced by donor-type cells. In chimeras of this
type, donor-derived HSC do colonize BM in low number (data not
shown). However, there is no clear evidence yet for L-DC develop-
ment in BM, although a similar but distinct subset of cells is under
further investigation.
A comparison of relative numbers of donor- versus host-
derived cells confirmed differing levels of chimerism for each cell
subset. A distinct trend in relative donor:host levels for different
DC subsets was evident across chimeras analysed at 15 to 18.5
weeks, despite variance in overall donor cell reconstitution levels
between individual mice. When the fold-increase in donor versus
host cell numbers was calculated for each APC subset and stan-
dardized to CD8 cDC (donor:host ratio 	 1.0), L-DC consis-
tently exceeded myeloid cells and cDC in terms of relative donor
to host cell contribution (Fig. 6). By this analysis, donor-derived
progenitors reconstituted CD8 cDC and CD8 cDC subsets to
equal levels, but gave ~2-fold more myeloid cells. These results
are developmentally consistent with a common progenitor (CDP)
for cDC subsets [16], and a common upstream progenitor (MDP)
for cDC and macrophages [13]. In contrast, donor-derived pro-
genitors gave rise to significantly higher numbers of L-DC (4–12
fold increase; mean 	 8.7) compared with CD8 cDC (Fig. 6),
perhaps indicative of a separate developmental origin for L-DC
compared with cDC and macrophages. Since this same trend was
also observed for control mice given only donor BM intravenously
(Figs 4 and 5), we concluded that the source of HSC was not
important. The lodgement of donor-type progenitors into empty
niches in spleen would appear to determine the development of L-
DC in higher relative numbers than other myeloid/dendritic cell
types in spleen.
Discussion
This study addresses myelopoiesis in spleen leading to the
development of a novel dendritic-like cell type, namely L-DC,
which is unique in terms of its phenotype and immune functional
potential [24]. Adult murine spleen is clearly an extramedullary
haematopoietic site containing low numbers of multipotent HSC
Fig. 5 Linckithi cells in adult spleen give
preferential reconstitution of L-DC. Chimeras
established in Figure 4 with donor Linckithi
spleen cells and host-type bone marrow, or
with host-type bone marrow alone, were
analysed for the presence of different
myeloid and DC subsets of both donor
(CD45.1) and host (CD45.2) type. Control
unirradiated host-type mice were given no
bone marrow. (A) The procedure for delin-
eation of myeloid and DC subsets is shown
for a control mouse, in the absence of
CD45.1/CD45.2 gating. The total population
of CD11b myeloid/dendritic cells was gated
from live (PI) T and B cell depleted spleno-
cytes, and then analysed for expression of
CD11c, MHC-II and CD8. Cell subsets gated
included: L-DC (FSChiCD11cloCD11bhiMHC-II),
CD8 cDC (CD11chiCD11bCD8MHC-II),
CD8 cDC (CD11chiCD11bCD8MHC-II)
and myeloid cells (FSCloCD11cCD11bhi
MHC-II). (B) Prevalence of myeloid/den-
dritic cell subsets in irradiation chimeras
reconstituted with either donor SPL ckithi
(ckit) or donor bone marrow (BM) cells is
shown in terms of percent cells amongst total of T and B cell depleted splenocytes. Distribution of spleen myeloid cell subsets in age-matched, unirradi-
ated mice is shown as a control. Results are shown as the mean  S.E. of three mice. (C) Representation of donor-derived (CD45.1) cells (L-DC, CD8
cDC, CD8 cDC and myeloid cells) in spleens of in ckithi SPL chimeras and BM chimeras compared with the myeloid subset composition of control donor-
type B6.SJL (CD45.1) mice.
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[1]. The hypothesis that extramedullary haematopoiesis medi-
ates the production of tissue-specific APC like L-DC with site-
specific functions, is consistent with compartmentalism of the
immune response to meet the needs of distinct tissue sites and
their respective pathogens. While multiple extramedullary sites
clearly contribute to haematopoiesis, the nature of cells pro-
duced and the conditions under which this occurs are not yet
well defined.
In order to identify an APC subset as distinct it is necessary to
show that the lineage origin and progenitor of those cells differs
from that of other common dendritic and myeloid subsets.
Marker analysis of adult spleen has led to the identification of
minor subsets of Linckitlo and Linckithi cells which lack mark-
ers like Flt3, CD34 and IL-7R associated with myeloid and lym-
phoid haematopoietic progenitor subsets in BM (Fig. 1) [17, 20].
There is already evidence that HSC in different tissue sites are dif-
ferent since the marker profile of foetal liver HSC differs from that
of BM HSC [40]. Here we have localized the progenitor of L-DC
within the Linckithi subset of spleen, which also contains LT-
HSC. The presence of LT-HSC in this subset was evident since
this subset gave long-term multilineage reconstitution of
chimeras out to 54 weeks (Fig. 6). This study therefore identifies
a close, if not linked, relationship between LT-HSC and the L-DC
progenitor in murine spleen. Further work is under way to obtain
the full marker expression profile of splenic HSC, and to deter-
mine whether this cell type differs from that of BM HSC with the
same differentiative capacity.
Both adult Linckitlo and Linckithi adult spleen subsets were
found to contain progenitors which differentiate to give L-DC in
co-culture over the STX3 splenic stroma. However, only the
Linckithi subset and not the Linckitlo subset contains cells,
which reflect self-renewing LT-HSC as demonstrated by their  
long-term multilineage reconstitution potential in irradiated mice.
The differential function of these two subsets in vivo did not mir-
ror their common in vitro differentiative capacity. A first explana-
tion is that they contain a common progenitor, not yet identifiable
with available antibodies. The second explanation is that the
Linckitlo subset contains L-DC progenitors that derive directly
from progenitors within the Linckithi subset of spleen, and that
this differentiation occurs when Linckithi cells are co-cultured
over STX3 stroma. The transition of Linckithi cells into Linckitlo
cells within co-cultures has proven very difficult to test because of
the small size of these subsets in spleen, and the difficulty of
recovering enough cells from co-cultures to perform an analysis
of phenotypic change.
Indeed, the L-DC progenitor in spleen is phenotypically distinct
from other described myeloid and dendritic progenitors present in
BM. The CDP and MDP are phenotypically Flt3 cells [13], with no
counterpart subset in spleen. The CDP has distinct differentiative
capacity for cDC, and the MDP differentiates to give macrophages
and DC [17]. Furthermore, neither the splenic Linckitlo nor
Linckithi subsets described here resemble the immediate cDC
precursor or pre-cDC subset previously identified as ckitCD11clo
cells, which respond to Flt3L to produce mature cDC and pDC [15,
18]. This pre-cDC subset would have been excluded by our sort-
ing protocol, which specifically gated out Lin cells including
CD11c DC.
L-DC are a distinct CD11cloCD11bhiMHC-II dendritic-like sub-
set in spleen with strong cross presentation capacity for CD8 T
cell activation [24]. While these cells are phenotypically distinct
from monocytes, which are CD11c and are also unable to cross
present antigen [24], it is not yet known whether L-DC share a
common lineage relationship with monocytes. Since monocytes,
macrophages and cDC /pDC all originate from BM progenitors like
MDP and CDP, one expectation is that these cell types might all be
reconstituted to similar levels following HSC transfer. This predic-
tion was in fact verified in radiation chimeras shown here, and
multiple chimeras demonstrated equal long-term reconstitution of
donor-derived splenic monocytes/macrophages, and the CD8
and CD8 cDC populations (Fig. 6). However, these same
chimeras showed an average 9-fold increase in donor over host
reconstitution of L-DC compared with CD8 cDC, and a 7-fold
Fig. 6 Linckithi adult spleen cells give pref-
erential reconstitution of L-DC in irradiation
chimeras. The long-term reconstituting
potential of Linckithi spleen cells for L-DC,
CD8 cDC, CD8 cDC and myeloid cells
was assessed in irradiation chimeras
described in Figure 4. These mice were
given a mix of donor-type Linckithi spleen
cells and host-type bone marrow. Controls
included two irradiation chimeras reconsti-
tuted with donor-type bone marrow. The
individual myeloid subsets of donor
(CD45.1) versus host (CD45.2) type were
identified in spleen using flow cytometry as
shown in Figure 5. The relative prevalence of donor:host cells for individual subsets was calculated for each animal, based on a relative value of 1.0 for
CD8 cDC. Mean  SE is shown for SPL chimeras (n 	 3). Cell subsets having significantly higher representation of donor:host-type cells compared
with CD8 cDC are indicated (*) [P  0.05 (Wilcoxon Rank Sum Test)].
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increase of L-DC over myeloid cells (Fig. 6). Further analyses
involving purified progenitors will be necessary in order to estab-
lish whether this result indicates independent development of L-
DC from macrophage/monocyte lineage cells.
Both in vivo and in vitro evidence now supports the hypothesis
that spleen endothelial cells represent a niche for haematopoiesis
of L-DC from spleen endogenous self-renewing HSPC. The pres-
ence of HSC in spleen has been demonstrated firstly by their abil-
ity to reconstitute lethally irradiated hosts [1] (Fig. 4), and secondly
since transplanted HSC can home to and engraft spleen [41]. In
this laboratory, we have also shown that L-DC progenitors are
maintained in spleen LTC, where they appear to continuously self-
renew for several years, in a manner strictly dependent on contact
with spleen endothelial cells [42]. This study therefore supports a
role for spleen as a tissue site supporting haematopoiesis for sub-
sequent production of L-DC. Indeed, a precedent already exists for
organ-specific DC haematopoiesis in skin [28]. At this stage, it is
not yet known whether L-DC development is an intrinsic property
of HSC maintained in spleen, or whether spleen stromal niches can
direct DC development from HSC originating from other tissues like
BM. Since mice reconstituted with either spleen- or BM-derived
HSC also show a strong bias towards donor-derived L-DC recon-
stitution over cDC and myeloid cells (Fig. 6), the spleen microenvi-
ronment rather than the tissue origin of HSC may be the critical fac-
tor in directing haematopoiesis of L-DC.
Indeed, an explanation for the bias in development of L-DC
over cDC and monocytes can be found in terms of niche space.
HSC transplanted intravenously into lethally irradiated mice seed
spleen with 37% frequency and BM with 50% frequency [41]. BM
contains multiple bone compartments [41] with endothelial and
osteoblastic niches, which support HSC development [43]. In con-
trast, spleen has both lower HSC prevalence [40] and less
endothelial niche space than BM, with no osteoblastic niches [43].
Therefore, based on HSC seeding frequency, and relative HSC
niche space between BM and spleen, it is likely that intravenously
transferred HSC engraft and saturate spleen HSC niches ahead of
BM niches, since they are fewer in number but comparable in
seeding frequency 1:1.3 ratio [41]. Saturation of niches in spleen
by intravenously delivered donor HSC could lead to higher devel-
opment of donor over host L-DC in spleen, if L-DC development is
dependent on splenic endothelial cells.
Evidence is advanced for a spleen-endogenous lineage of den-
dritic-like cells which develop under steady-state conditions. Both
in vivo and in vitro studies support this conclusion that LTC estab-
lished from neonatal spleen continuously produce L-DC, the adult
spleen Linckit subset contains L-DC progenitors, and adult
spleen HSC can reconstitute L-DC to a greater extent than other
DC or myeloid subsets. Such a model for spleen-specific DC
haematopoiesis will require testing under conditions where cell
development is monitored from HSPC engrafted into spleen, but
in the absence of BM engraftment.
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